Occurrence, predictors, and outcomes of post-percutaneous coronary intervention thrombocytopenia in an unselected population

Journal of Interventional Cardiology

Volumn 22, Issue 2, 2009, Pages 156-162

  Shenoy, Chetan ^a   Orshaw, Pamela ^a   Devarakonda, Srinivas ^a   Harjai, Kishore J ^a  

^a GUTHRIE RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANGIOGRAPHY; ARTICLE; CARDIOVASCULAR SYMPTOM; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REVASCULARIZATION; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CARDIOVASCULAR DISEASES; COHORT STUDIES; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PENNSYLVANIA; PROGNOSIS; QUESTIONNAIRES; REGISTRIES; RISK FACTORS; THROMBOCYTOPENIA; TREATMENT OUTCOME;

EID: 64149111296     PISSN: 08964327     EISSN: 15408183     Source Type: Journal    
DOI: 10.1111/j.1540-8183.2009.00424.x     Document Type: Article

References (21)

1. Bovill EG, Terrin ML, Stump DC, et al. Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction: Results of the Thrombolysis in Myocardial Infarction (TIMI), Phase II Trial. Ann Intern Med 1991 115 (4 256 265.
2. Harrington RA, Sane DC, Califf RM, et al. Clinical importance of thrombocytopenia occurring in the hospital phase after administration of thrombolytic therapy for acute myocardial infarction. The Thrombolysis and Angioplasty in Myocardial Infarction Study Group. J Am Coll Cardiol 1994 23 (4 891 898.
3. Nikolsky E, Sadeghi HM, Effron MB, et al. Impact of in-hospital acquired thrombocytopenia in patients undergoing primary angioplasty for acute myocardial infarction. Am J Cardiol 2005 96 (4 474 481.
4. Berkowitz SD, Sane DC, Sigmon KN, et al. Occurrence and clinical significance of thrombocytopenia in a population undergoing high-risk percutaneous coronary revascularization. Evaluation of c7E3 for the Prevention of Ischemic Complications (EPIC) Study Group. J Am Coll Cardiol 1998 32 (2 311 319.
5. Berkowitz SDGC, Thompson T, Kleiman NS, et al. Thrombocytopenia was associated with greater hemorrhage and higher mortality in GUSTO IIb trial. Thromb Haemost 1997 236 : PS 962.
6. Berkowitz SDSR, Califf RM, Cohen M. Occurrence and significance of thrombocytopenia in unstable angina and non-Q-wave infarction in the ESSENCE trial. Blood 1997 90 : 81b.
7. McClure MW, Berkowitz SD, Sparapani R, et al. Clinical significance of thrombocytopenia during a non-ST-elevation acute coronary syndrome. The platelet glycoprotein IIb/IIIa in unstable angina: Receptor suppression using integrilin therapy (PURSUIT) trial experience. Circulation 1999 99 (22 2892 2900.
8. Merlini PA, Rossi M, Menozzi A, et al. Thrombocytopenia caused by abciximab or tirofiban and its association with clinical outcome in patients undergoing coronary stenting. Circulation 2004 109 : 2203 2206.
9. Hill ME, Rosenwaike I. The Social Security Administration's Death Master File: The completeness of death reporting at older ages. Soc Secur Bull 2001 64 : 45 51.
10. Newman TB, Brown AN. Use of commercial record linkage software and vital statistics to identify patient deaths. J Am Med Inform Assoc 1997 4 : 233 237.
11. Schisterman EF, Whitcomb BW. Use of the Social Security Administration Death Master File for ascertainment of mortality status. Popul Health Metr 2004 2 : 2. Available online at http://www.pophealthmetrics.com/content/2/1/2 (accessed February 10, 2009).
12. Chesebro JH, Knatterud G, Roberts R, et al. Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation 1987 76 : 142 154.
13. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. The EPILOG Investigators. N Engl J Med 1997 336 (24 1689 1696.
14. Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade. Lancet 1998 352 (9122 87 92.
15. Gonzalez-Ponte ML, Gonzalez-Ruiz M, Duvos E, et al. Atorvastatin-induced severe thrombocytopenia. Lancet 1998 352 : 1284.
16. Groneberg DA, Barkhuizen A, Jeha T. Simvastatin-induced thrombocytopenia. Am J Hematol 2001 67 (4 277.
17. McCarthy LJ, Porcu P, Fausel CA, et al. Thrombotic thrombocytopenic purpura and simvastatin. Lancet 1998 352 : 1284 1285.
18. Grosbois B, Milton D, Beneton C, et al. Thrombocytopenia induced by angiotensin converting enzyme inhibitors. BMJ 1989 298 : 189 190.
19. Bennett CL, Connors JM, Carwile JM, et al. Thrombotic thrombocytopenic purpura associated with clopidogrel. N Engl J Med 2000 342 : 1773 1777.
20. Vonderheide RH, Thadhani R, Kuter DJ. Association of thrombocytopenia with the use of intra-aortic balloon pumps. Am J Med 1998 105 : 27 32.
21. Mattichak SJ, Dixon SR, Shannon F, et al. Failed percutaneous coronary intervention: A decade of experience in 21,000 patients. Catheter Cardiovasc Interv 2008 71 : 131 137.